FIT4PEDON:儿童癌症幸存者的移动营养咨询应用程序的有效性和可用性
R Bavatharani1, V Supriya1, Julius Xavier Scott2
1Department of Clinical Nutrition, Sri Ramachandra Faculty of Allied Health Sciences, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, India.
Healthcare informatics research
|February 20, 2025
概括
移动应用FIT4PEDON显示了改善儿童癌症幸存者的饮食行为. 需要进一步的研究来完善其在专家年龄组的有效性.
科学领域:
- 数字健康数字健康
- 营养咨询 营养咨询
- 儿科瘤学幸存率 儿童瘤学幸存率
背景情况:
- 移动应用程序提供了传统面对面营养咨询的替代方案.
- 儿童癌症幸存者 (CCS) 需要持续支持健康生活方式的修改.
研究的目的:
- 开发和评估FIT4PEDON移动营养咨询应用程序的可用性和有效性.
- 在CCS中促进健康的饮食行为和生活方式的改变.
主要方法:
- 使用调查和定性/定量分析的混合方法方法.
- 涉及33名医疗保健专业专家.
- 评估了问卷的可靠性 (Kuder-Richardson) 和内容的有效性 (专家评估);进行了可用性测试.
主要成果:
- 开发了一个Android移动应用程序和一个管理网页应用程序.
- 很大一部分专家支持这款用于饮食管理的应用程序.
- 统计分析显示了响应的显著差异,但性别或年龄组之间没有显著差异.
结论:
- 该FIT4PEDON应用程序显示了支持CCS采用更健康的生活方式的潜力.
- 建议进行进一步的研究,专注于特定的专家年龄组,以获得更具结论性的发现.
- 移动健康技术可以提高儿童癌症幸存者的生存护理质量和长期参与.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321


